Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen

Endocrinology

Volumn 144, Issue 5, 2003, Pages 1812-1824

  Boyan, Barbara D ^a   Sylvia, V L ^b   Frambach, T ^c   Lohmann, C H ^d   Dietl, J ^c   Dean, D D ^b   Shwartz, Z ^a,b,e  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Eppendorf University   (Germany)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROTEIN KINASE C; TAMOXIFEN; ANTIESTROGEN; BOVINE SERUM ALBUMIN; CONJUGATED ESTROGEN; ESTRADIOL BOVINE SERUM ALBUMIN; ESTRADIOL-BOVINE SERUM ALBUMIN;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA SYNTHESIS; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR RECURRENCE; ADULT; AGED; BREAST TUMOR; CELL CULTURE; DRUG ANTAGONISM; FEMALE; MEMBRANE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; TIME;

ADULT; AGED; BREAST NEOPLASMS; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEMBRANES; MIDDLE AGED; PROTEIN KINASE C; RECEPTORS, ESTROGEN; SERUM ALBUMIN, BOVINE; TAMOXIFEN; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0037734126     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-221018     Document Type: Article

References (66)

1. O'Brian CA, Vogel VG, Singletary SE, Ward NE 1989 Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 49:3215-3217
2. Gordge PC, Hulme MJ, Clegg RA, Miller WR 1996 Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer 32A:2120-2126
3. Gupta KP, Ward NE, Gravitt KR, Bergman PJ, O'Brian CA 1996 Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-α pseudosubstrate peptide. J Biol Chem 271:2102-2111
4. Bergman PJ, Gravitt KR, O'Brian CA 1997 An N-myristoylated protein kinase C-α pseudosubstrate peptide that functions as a multidrug resistance reversal agent in human breast cancer cells is not a P-glycoprotein substrate. Cancer Chemother Pharmacol 40:453-456
5. Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant, WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ 1995 MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95:1906-1915
6. Persons DA, Wilkison WO, Bell RM, Finn OJ 1988 Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA. Cell 52:447-458
7. Su ZZ, Shen R, O'Brian CA, Fisher PB 1994 Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C β 1 gene and reversal of progression by 5-azacytidine. Oncogene 9:1123-1132
8. Lavie Y, Zhang ZC, Cao HT, Han TY, Jones RC, Liu YY, Jarman M, Hardcastle IR, Giuliano AE, Cabot MC 1998 Tamoxifen induces selective membrane association of protein kinase C ε in MCF-7 human breast cancer cells. Int J Cancer 77:928-932
9. Fabbro D, Kung W, Roos W, Regazzi R, Eppenberger U 1986 Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res 46:2720-2725
10. Sylvia VL, Hughes T, Dean DD, Boyan BD, Schwartz Z 1998 17β-Estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanisms. J Cell Physiol 176:435-444
11. Winter DC, Taylor C, O'Sullivan GC, Harvey BJ 2000 Mitogenic effects of oestrogen mediated by a non-genomic receptor in human colon. Br J Surg 87:1684-1689
12. Sylvia VL, Schwartz Z, Schuman L, Morgan RT, Mackey S, Gomez R, Boyan BD 1993 Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocytes cultures. J Cell Physiol 157:271-278
13. Schwartz Z, Gates PA, Nasatzky E, Sylvia VL, Mendez J, Dean DD, Boyan BD 1996 Effect of 17β-estradiol on chondrocyte membrane fluidity and phospholipid metabolism is membrane-specific, sex-specific, and cell maturation-dependent. Biochim Biophys Acta 1282:1-10
14. Levin ER 2001 Cell localization, physiology, and nongenomic actions of estrogen receptors. J Applied Physiol 91:1860-1867
15. Sylvia VL, Boyan BD, Dean DD, Schwartz Z 2000 The membrane effects of 17β-estradiol on chondrocyte phenotypic expression are mediated by activation of protein kinase C through phospholipase C and G-proteins. J Steroid Biochem Mol Biol 73:211-224
16. Nasatzky E, Schwartz Z, Soskolne WA, Brooks BP, Dean DD, Boyan BD, Ornoy A 1994 Sex steroid enhancement of matrix production by chondrocytes is sex and cell maturation specific. Endocr J 2:207-215
17. Sapino A, Pietribiasi F, Bussolati G, Marchisio PC 1986 Estrogen- and tamoxifen-induced rearrangement of cytoskeletal and adhesion structures in breast cancer MCF-7 cells. Cancer Res 46:2526-2531
18. Stefaneanu L 1997 Pituitary sex steroid receptors: localization and function. Endocr Pathol 8:91-108
19. Goldenberg GJ, Froese EK 1982 Drug and hormone sensitivity of estrogen receptor-positive and-negative human breast cancer cells in vitro. Cancer Res 42:5147-5151
20. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE 1999 Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140:5455-5458
21. Sylvia VL, Walton J, Lopez D, Dean DD, Boyan BD, Schwartz Z 2001 17β-estradiol-BSA conjugates and 17β-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J Cell Biochem 81:413-429
22. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC 2001 Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730
23. Swain SM 2001 Tamoxifen for patients with estrogen receptor-negative breast cancer. J Clin Oncol 19:93S-97S
24. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB 1985 Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462-2465
25. Schwartz Z, Sylvia VL, Guinee T, Dean DD, Boyan BD 2002 Tamoxifen elicits its anti-estrogen effects in growth plate chondrocytes by inhibiting PKC. J Steroid Bioehem Mol Biol 80:401-410
26. Horwitz KB, Zava DT, Thilagar AK, Jensen EM, McGuire WL 1978 Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res 38:2434-2437
27. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba I, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD, Shay JW 1998 Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer 78:766-774
28. Jain PT, Trump BF1997 Tamoxifen induces deregulation of [Ca2+] in human breast cancer cells. Anticancer Res 17:1167-1174
29. Mandlekar S, Kong AN 2001 Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6:469-477
30. Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, Grimshaw R, Jarman M, Dowsett M 1999 Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Cancer Res 59:3646-3651.
31. Inoue S, Hoshino S, Miyoshi H, Akishita M, Hosoi T, Orimo H, Ouchi Y 1996 Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem Biophys Res Comm 219:766-772
32. Robertson JF 2001 ICI 182, 780 (Fulvestrant)-the first oestrogen receptor down-regulator: current clinical data. Br J Cancer 85(Suppl 2):11-14
33. Wakeling AE 1995 Use of pure anti-estrogens to elucidate the mode of action of estrogens. Biochem Pharmacol 49:1545-1549
34. Fuqua SA 1999 Expression of wild-type estrogen receptor and variant isoforms in human breast cancer. Cancer Res 59:4525-4528
35. Norfleet AM, Clarke CH, Gametchu B, Watson CS 2000 Antibodies to the estrogen receptor-α modulate rapid prolactin release from rat pituitary tumor cells through plasma membrane estrogen receptors. FASEB J 14:157-165
36. Bleasdale J, Bundy GL, Bunting S, Fitzpatrick FA, Huff RM, Sun FF, Pike JE 1989 Inhibition of phospholipase C-dependent processes by U73, 122. Adv Prostaglandin Thromboxane Leukot Res 19:590-593
37. Perez DM, DeYoung MB, Graham RM 1993 Coupling of expressed α 1B- and α 1D-adrenergic receptor to multiple signaling pathways is both G protein and cell type specific. Mol Pharmacol 44:784-795
38. Church DJ, Braconi S, van der Brent V, Vallotton MB, Lang U1994 Protein kinase C-dependent prostaglandin production mediates angiotensin II-induced atrial-natriuretic peptide release. Biochem J 298:451-456
39. Sylvia VL, Gay I, Hardin R, Dean DD, Boyan BD, Schwartz Z 2002 Rat costochondral chondrocytes produce 17β-estradiol and regulate its production by 1α,25(OH)2D3. Bone 30:57-63
40. Remmele W, Stegner HE 1987 Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138-140
41. World Health Organization, Histological typing of breast tumors. 2nd ed. Geneva, 1981. Ann Pathol 2:91-105
42. Zheng J, Ali A, Ramirez VD 1996 Steroids conjugated to bovine serum albumin as tools to demonstrate specific steroid neuronal membrane binding sites. J Psychiatry Neurosci 21:187-197
43. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM 2002 Estrogen-mediated neuroproteetion against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway. J Neurochem 82:674-682
44. Alvaro D, Onori P, Metalli VD, Svegliati-Baroni G, Folli F, Franchitto A, Alphini G, Mancino MG, Attili AF, Gaudio E 2002 Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat. Hepatology 36:297-304
45. Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB 2002 MAP kinase/estrogen receptor cross-talk enhances estrogen-medicated signaling and tumor growth but does not confer tamoxifen resistance. Oneogene 21:4000-4008
46. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y 1982 Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257:7847-7851
47. Darbon, J-M, Valette A, Bayard F 1986 Phorbol esters inhibit the proliferation of MCF-7 cells. Biochem Pharmacol 35:2683-2686
48. Zhang L, Zhai X, He Z 2000 Modulating effect of vitamin D3 in vitro on EGFR mRNA expression of human breast cancer cell lines. Zhonghua Zhong Liu Za Zhi 22:205-207
49. Swiatecka J, Dzieciol J, Anchim T, Dabrowska M, Pietruczuk M, Wolczynski S 2000 Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cells culture. Neoplasma 47:15-24
50. Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS 2000 Differences in protein kinase C and estrogen receptor α, β expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Int J Oncol 16:1179-1187
51. Basu A 1998 The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells tumor necrosis factor-α. Mol Pharmacol 53:105-111
52. Sutherland RL, Hall RE, Taylor IW 1983 Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res 43:3998-4006
53. Herbert JM, Augereau JM, Gleye J, Maffrand JP 1990 Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172:993-999
54. Bang J, Belcheva MM, Coscia CJ 1992 Evidence for the implication of phosphoinositol signal transduction in μ-opioid inhibition of DNA synthesis. J Neurochem 59:1145-1152
55. Azarani A, Goltzman D, Orlowski J 1995 Parathyroid hormone and parathyroid hormone-related peptlde inhibit the apical Na+/H+ exchanger NHE-3 isoform in renal cells (OK) via a dual signaling cascade revolving protein kinase A and C. J Biol Chem 270:20004-20010
56. O'Brian CA, Housey GM, Weinstein IB 1988 Specific and direct binding of protein kinase C to an immobilized tamoxifen analogue. Cancer Res 48:3626-3629
57. Lam HY 1984 Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Biochem Biophys Res Commun 118:27-32
58. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB 1986 Triphenylethylenes: a new class of protein kinase C inhibitors. J Natl Cancer Inst 76:1243-1246
59. Katzenellenbogen BS 1996 Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 54:287-293
60. Purohit A, Flanagan AM, Reed MJ 1992 Estrogen synthesis by osteoblast cell lines. Endocrinology 131:2027-2029
61. James VH, McNeill JM, Lai LC, Newton CJ, Ghilchik MW, Reed MJ 1987 Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50:269-279
62. Duncan LJ, Reed MJ 1995 The role and proposed mechanism by which oestradiol 17β-hydroxysteroid dehydrogenase regulates breast tumour oestrogen concentrations. J Steroid Biochem Mol Biol 55:565-572
63. Bell RM, Hannun Y, Loomis C 1986 Mixed micelle assay of protein kinase C. Methods Enzymol 124:353-359
64. Schondorf T, Kurbacher C, Becker M, Warm M, Kolhagen H, Gohring U 2001 Heterogeneity of protein kinase C activity and PKC-ζ expression in clinical breast carcinomas. Clin Exp Med 1:1-8
65. Liyanage M, Frith D, Livneh E, Stabel S 1992 Protein kinase C group B members PKC-δ, -ε, -ζ of recombinant proteins in vitro and in vivo. Biochem J 283:781-787
66. Masso-Welch P, Winston J, Edge S, Darcy K, Asch H, Vaughan M, Ip M 2001 Altered expression and localization of PKC ε in human breast tumors. Breast Cancer Res Treat 68:211-223